2 years ago
ARQT
AnalystsUy EarUy Ear's Stock Forecasts
AnalystsUy Ear
Analyst Ranking
Top 16%
#822 out of 5314 analysts
Average Return
+17.16%
Win Rate
53%31 out of 59
Risk vs Reward
Poor
Good
Uy Ear's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Mbx Biosciences IncMBX | +383.68% | $11.95 | $57.80 | 2025-08-05 - 2026-07-02 | Buy |
Arcutis Biotherapeutics IncARQT | +306.12% | $3.43 | $13.93 | 2024-01-02 - 2024-12-31 | Strong Buy |
Arcutis Biotherapeutics IncARQT | +272.38% | $3.91 | $14.56 | 2024-01-03 - 2025-01-02 | Strong Buy |
Mbx Biosciences IncMBX | +187.56% | $20.10 | $57.80 | 2025-09-24 - 2026-07-02 | Buy |
Uniqure NvQURE | +138.10% | $17.56 | $41.81 | 2026-03-11 - 2026-07-02 | Buy |
Uy Ear Analyst Color
Get additional color on Uy Ear's coverage of popular stocks
Uy Ear's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alkermes PLCALKS | 7 | Buy | $65.00 | +19.09% | Maintains | 3 days ago |
Uniqure NvQURE | 9 | Buy | $68.00 | +62.64% | Maintains | 9 days ago |
Sol Gel Technologies LtdSLGL | 1 | Buy | $285.00 | +285.08% | Initiates Coverage On | 11 days ago |
Relmada Therapeutics IncRLMD | 3 | Buy | $19.00 | +202.55% | Maintains | 3 months ago |
Sarepta Therapeutics IncSRPT | 9 | Buy | $31.00 | +60.79% | Maintains | 4 months ago |
Arcutis Biotherapeutics IncARQT | 15 | Buy | $35.00 | +35.61% | Maintains | 4 months ago |
Acadia Pharmaceuticals IncACAD | 16 | Buy | $35.00 | +34.77% | Upgrades | 4 months ago |
Neurocrine Biosciences IncNBIX | 10 | Hold | $175.00 | +0.42% | Maintains | 7 months ago |
Evolus IncEOLS | 4 | Buy | $19.00 | +175.36% | Maintains | 7 months ago |
Mbx Biosciences IncMBX | 2 | Buy | $56.00 | -3.11% | Maintains | 9 months ago |
Tectonic Therapeutic IncTECX | 6 | Buy | $85.00 | N/A | Maintains | a year ago |
Sage Therapeutics IncSAGE | 2 | Hold | $16.00 | N/A | Maintains | 2 years ago |
Cartesian Therapeutics IncRNAC | 3 | Strong Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $16.00 | N/A | Maintains | 3 years ago |
Johnson & JohnsonJNJ | 1 | Strong Buy | $40.00 | N/A | Maintains | 3 years ago |
Satsuma Pharmaceuticals IncSTSA | 1 | Hold | $2.00 | N/A | Reiterates | 3 years ago |
Cabaletta Bio IncCABA | 1 | Strong Buy | $10.00 | N/A | Reiterates | 3 years ago |
Ocugen IncOCGN | 2 | Strong Buy | $3.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.